Taysha Gene Therapies (Nasdaq: TSHA) announced the pricing of an underwritten public offering totaling approximately $200 million. The offering includes 32,500,001 common shares at $6.00 each and pre-funded warrants for 833,333 shares at $5.999 each, with an option for underwriters to purchase an additional 5,000,000 shares. The closing is expected around June 26, 2026, subject to customary conditions, with proceeds intended to support the company's gene therapy programs.

Taysha Gene Therapies announced the pricing of a public offering of 32,500,001 shares of common stock at $6.00 per share and pre-funded warrants for 833,333 shares at $5.999 per warrant. The company expects to raise approximately $200.0 million from this offering, which is anticipated to close around June 26, 2026. This capital raise will support the clinical-stage biotechnology company's work on AAV-based gene therapies for severe monogenic diseases of the central nervous system.

Bank of New York Mellon Corp (BK) has announced intentions to increase its quarterly cash dividend by 19% to $0.63 per share, pending board approval. The company's Stress Capital Buffer (SCB) requirement remains at the 2.5% floor following the 2026 Federal Reserve stress tests, and its existing share repurchase program continues. These actions demonstrate BNY Mellon's strong capital position and commitment to returning capital to shareholders, although future regulatory changes in 2027 could impact capital requirements.

Taysha Gene Therapies has priced an underwritten public offering of 32,500,001 shares of common stock at $6.00 per share, aiming to raise approximately $200 million. The company also offered pre-funded warrants and granted underwriters a 30-day option for additional shares. This offering occurs while TSHA shares are trading above the offering price, having seen a 184% return over the past year.

DuPont de Nemours, Inc. (DD) has announced a 1-for-3 reverse stock split and a proportional reduction in authorized shares, effective June 24, 2026. This strategic move, approved by stockholders and the Board of Directors, aims to streamline the company's capital structure and potentially enhance shareholder value. DuPont common stock will continue trading on the NYSE under "DD" with a new CUSIP number.

U.S. Bancorp (USB) announced its Stress Capital Buffer (SCB) will remain at 2.6% until October 1, 2027, indicating confidence in its capital position. The company also plans to increase its quarterly common stock dividend from $0.52 to $0.54 per share starting in Q3 2026, subject to board approval. These actions highlight U.S. Bancorp's focus on financial stability, regulatory compliance, and rewarding shareholders.

Iron Mountain Inc. stock recently reached an all-time high of $134.23, now trading slightly higher at $134.68, reflecting significant investor confidence with a 63% year-to-date return. This surge follows impressive financial results for Q1 2026, where the company surpassed EPS and revenue forecasts and announced an upsized offering of $1.5 billion in senior notes. These developments underscore Iron Mountain’s robust performance and strategic financial management.

BetMGM and MGM Resorts International have extended their partnerships with Major League Baseball (MLB), continuing a relationship that began in 2018. BetMGM will promote its brand and sports betting offerings across MLB's media ecosystem and develop co-branded games, while MGM Resorts remains MLB's exclusive Integrated Resort and Casino Partner, enhancing fan experiences and supporting league events. Both companies and MLB officials emphasized the deal's importance for long-term strategies, innovation, and fan engagement.

Taseko Mines Limited announced the voting results from its 2026 Annual General Meeting, where shareholders approved the change of the company's name to Trekor Metals Limited, effective June 25, 2026. All director nominees were elected, and other business items, including executive compensation and amendments to the deferred share unit plan, were also approved. The company's common shares will begin trading under the new name on June 29, 2026, on the TSX and NYSE and on June 30, 2026, on the LSE, with ticker symbols remaining unchanged, but the CUSIP and ISIN will be updated.

Toyota is projected to significantly narrow the sales gap with General Motors in the U.S. market for the first half of the year, driven by a nearly 1% increase in its sales and a strong focus on hybrid vehicles. In contrast, GM is expected to see a 7.2% decline in sales, as its emphasis on electric vehicles faces challenges in consumer adoption. This trend suggests Toyota could potentially overtake GM in U.S. sales again by year-end, driven by consumer preference for hybrid powertrains amidst an overall decline in new vehicle sales and a significant drop in EV sales.